GLP-1 Provider Guide: How to Compare Online Weight-Loss Medication Programs
People searching for GLP-1 help are usually trying to answer four questions at once: which medication, which provider, what will it cost, and how do I eat when appetite changes. This hub separates those decisions.
Summary
Start with medication legitimacy: FDA-approved brand-name drugs, manufacturer cash-pay programs, insurance pathways, and compounded-drug caveats are different categories. Then compare providers by total monthly cost, follow-up care, labs, pharmacy transparency, and whether they support nutrition beyond the prescription. After starting therapy, Alma can be the common nutrition layer across providers: protein, fiber, micronutrients, hydration, meal quality, and consistency.
The decision tree
If you have insurance coverage: start with your plan, your clinician, and programs that help with prior authorization. PlushCare and Ro are examples of providers that may fit an insurance-navigation workflow without turning this guide into a nutrition-app comparison.
If you are cash-pay: compare manufacturer direct pricing first. LillyDirect and NovoCare have lowered self-pay pricing for some FDA-approved options. Then compare telehealth programs against that baseline.
If you are considering compounded GLP-1s: read the FDA warnings first. Compounded products are not FDA-approved for safety, effectiveness, or quality, and the legal environment changed after GLP-1 shortages resolved.
Keyword-backed page strategy
Keyword Planner showed that the strongest opportunity is not one generic page. It is a cluster: medication comparison, cost/coupon pages, provider review pages, compounded-safety pages, and nutrition-support pages. That is why this hub links to each focused resource instead of trying to rank one giant page for every intent.
Provider comparison snapshot
| Provider | Best fit | Pricing signal | Watch-out |
|---|---|---|---|
| Fridays | People comparing low cash-pay programs and wanting bundled coaching, dietitian support, and community. | Advertised pricing has included semaglutide from $117-$150/mo during promotions. Fridays states it is cash-pay and does not accept insurance. | Compounded medications are not FDA-approved. Confirm current formulation, pharmacy, refund terms, and whether a brand-name option is available before paying. |
| Ro | People who want a polished digital experience and are open to FDA-approved brand-name options. | Ro lists Wegovy pill pricing from $149 for the first month and $199-$299 thereafter, with an additional Ro Body membership fee required. | The medication price and membership fee are separate. Dose, eligibility, and insurance status can change the real monthly cost. |
| Hers | People who already prefer the Hims/Hers telehealth experience and want an FDA-approved semaglutide path. | Hers lists Wegovy pill from $149/mo, Wegovy pen from $199/mo, and Zepbound at $1,899/mo, plus a membership listed as $39 for the first month and $149/mo thereafter. | Membership and medication are billed separately. Recent Hims & Hers strategy shifted toward FDA-approved Novo Nordisk products, so verify what is currently offered. |
| Eden | People comparing low advertised cash prices and willing to investigate compounded-drug risk carefully. | Eden content states compounded semaglutide starts at $149 for the first month, then $249/mo. Eden also notes compounded tirzepatide may cost about $250-$500/mo. | Eden itself notes compounded products are not FDA-approved for safety, efficacy, or quality. Ask exactly which pharmacy, ingredient form, and legal basis applies. |
| Mochi Health | People looking for transparent membership-plus-medication pricing and ongoing clinician messaging. | Mochi content describes a $79/mo membership plus compounded GLP-1 medications at $99/mo for semaglutide or $199/mo for tirzepatide. | The quoted pricing is from Mochi comparison content. Confirm the current checkout, compounding status, and medication legality before relying on it. |
| Walgreens Weight Management | People who want a pharmacy-linked, no-subscription path and already know they are paying cash. | Walgreens lists initial video visits from $49 and GLP-1 treatment as low as $149/mo for self-paying patients, using manufacturer savings terms for select medications. | Walgreens says the service is currently intended for out-of-pocket payment and does not handle GLP-1 insurance prior authorizations. |
| PlushCare | People who want physician visits and insurance prior-authorization help rather than a bundled cash-pay medication program. | PlushCare notes cash cost without insurance can be roughly $1,000/mo and says its care team can help with prior authorization when needed. | Expect separate visit, membership, lab, and pharmacy costs. Cash-pay brand-name medication can still be expensive. |
Alma is the nutrition layer, not the prescriber
Alma does not prescribe GLP-1 medication. Alma is the companion tracker that can sit beside any prescriber or pharmacy path: log meals quickly, keep protein and fiber visible, watch micronutrient gaps, and make reduced appetite easier to manage without losing food confidence.
How Alma Helps
Alma supports the nutrition side of GLP-1 care. It does not prescribe medication.